Roche will publish its Sales Results for the 1^st Quarter of 2020 prior to the opening of the Swiss Stock Exchange on Wednesday, April 22^nd, 2020

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here
Presentation slides will be posted on the Roche IR website > click here

We would like to invite all interested parties to dial in as outlined below:

14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

Audio webcast and conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers).

Presenters:

• Severin Schwan, CEO Roche Group
• Bill Anderson, CEO Roche Pharmaceuticals
• Thomas Schinecker, CEO Roche Diagnostics
• Alan Hippe, Chief Financial and IT Officer
  
  

To expedite the registration process on the day of the conference call, you may pre-register for the event > click here


Alternatively you may dial in to the conference 10-15 min prior to the scheduled start using the following numbers:
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
Other international numbers are available here


Best regards,


Karl Mahler
Head of Investor Relations and Roche Group Planning

Attachment

• 200422_Invitation Q1